Home LiteratureArticle Details
PMID: 893674 Published · ppublish English Case Reports Journal Article Research Support, U.S. Gov't, P.H.S.

Absence of the eighth component of complement in association with systemic lupus erythematosus-like disease.

The Journal of clinical investigation ·Vol. 60 ·No. 3 ·1977-09-00 ·Pages 709-15

Jasin HE

Abstract

A 56-yr-old black woman with absence of the eighth component of complement and a disease compatible with systemic lupus erythematosus is described. Her disease is characterized by the presence of photosensitive "malar" rash, alopecia, polyarthritis, and nephrotic syndrome. Hemolytic and immunochemical assays of the serum complement components were normal, except for C8 which was undetectable. Hemolytic activity could be restored to normal by the addition of functionally pure C8. In vitro tests to investigate the functional integrity of the classical and alternative pathways indicated that the functions mediated by activation of C3 and C5 were intact whereas heatlabile bactericidal activity was totally absent. Addition of C8 restored this function to normal levels. One of two brothers of the proband was shown to have serum C8 levels approaching 50% of normal indicating the hereditary nature of the defect. HLA typing studies showed that the normal brother had identical haplotypes to the proband while the proposed heterozygous brother only shared one haplotype with the patient, suggesting that the gene controlling the C8 defect was not closely linked to the major histocompatibility complex. If the association of a connective tissue disease and absence of a terminal component of complement is not coincidental, these results suggest that C8 deficiency may be associated with a subtle defect in the defense mechanisms to viral infection leading to viral persistance and perhaps to diseases such as systemic lupus erythematosus where chronic viral infections have been implicated.

MeSH Terms
Complement C8/deficiency Complement System Proteins/deficiency Female Genetic Linkage Histocompatibility Humans Lupus Erythematosus, Systemic/diagnosis,immunology Middle Aged
Chemicals
Complement C8 Complement System Proteins
Authors & Affiliations
1 authors, click to expand affiliations / ORCID
Jasin H E
References (39)
39 references, click to expand
  1. IN VIVO BEHAVIOR OF I-FIBRINOGEN.
    J Clin Invest. 1963 Mar;42(3):346-61 PMID: 16695897
  2. ANTIGEN-ANTIBODY CROSSED ELECTROPHORESIS.
    Anal Biochem. 1965 Feb;10:358-61 PMID: 14302464
  3. THE ROLE OF SERUM COMPLEMENT IN CHEMOTAXIS OF LEUKOCYTES IN VITRO.
    J Exp Med. 1965 Aug 1;122:327-46 PMID: 14316948
  4. ISOLATION OF BETA IF-GLOBULIN FROM HUMAN SERUM AND ITS CHARACTERIZATION AS THE FIFTH COMPONENT OF COMPLEMENT.
    J Exp Med. 1965 Aug 1;122:277-98 PMID: 14316946
  5. IMMUNE BACTERICIDAL ACTIVITY OF COMPLEMENT. SEPARATION AND DESCRIPTION OF INTERMEDIATE STEPS.
    J Immunol. 1964 Aug;93:319-30 PMID: 14202263
  6. The chemotactic effect of mixtures of antibody and antigen on polymorphonuclear leucocytes.
    J Exp Med. 1962 Mar 1;115:453-66 PMID: 13872176
  7. Lysis of RNA tumor viruses by human serum: direct antibody-independent triggering of the classical complement pathway.
    J Exp Med. 1976 Oct 1;144(4):970-84 PMID: 62019
  8. The chromosomal order of genes controlling the major histocompatibility complex, properdin factor B, and deficiency of the second component of complement.
    J Clin Invest. 1976 Nov;58(5):1240-8 PMID: 993342
  9. Chromosome 6: linkage of the eighth component of complement (C8) to the histocompatibility region (HLA).
    Cytogenet Cell Genet. 1976;16(1-5):331-4 PMID: 975903
  10. Inherited deficiency of the second component of complement. Rheumatic disease associations.
    J Clin Invest. 1976 Oct;58(4):853-61 PMID: 965492
  11. Generation of chemotactic factors in guinea pig serum via activation of the classical and alternate complement pathways.
    Clin Immunol Immunopathol. 1973 Apr;1(3):414-26 PMID: 4201402
  12. The C3-activator system: an alternate pathway of complement activation.
    J Exp Med. 1971 Sep 1;134(3 Pt 2):90s-108s PMID: 4105810
  13. Immune lytic transformation: a state of irreversible damage generated as a result of the reaction of the eighth component in the guinea pig complement system.
    J Immunol. 1968 Jan;100(1):46-54 PMID: 4169697
  14. Precipitin reactions of the C1q component of complement with aggregated gamma-globulin and immune complexes in gel diffusion.
    Immunology. 1970 Dec;19(6):909-19 PMID: 4098878
  15. Neutralization of sensitized virus by purified components of complement.
    Proc Natl Acad Sci U S A. 1970 Mar;65(3):528-35 PMID: 4315612
  16. A new one-step method for the functional assay of the fourth component (C4) of human and guinea pig complement.
    J Immunol. 1974 Aug;113(2):574-83 PMID: 4210883
  17. Editorial: Systemic lupus erythematosus and type C RNA viruses.
    N Engl J Med. 1976 Aug 26;295(9):501-2 PMID: 59901
  18. Human heat labile opsonins: evidence for their mediation via the alternate pathway of complement activation.
    J Immunol. 1972 Jul;109(1):26-31 PMID: 4624675
  19. Genetic abnormalities of the complement system of man associated with disease.
    Transplant Proc. 1974 Mar;6(1):59-65 PMID: 4593655
  20. Genetic aspects of diseases of complement: an explosion.
    Am J Med. 1975 Jan;58(1):105-11 PMID: 46701
  21. The role of the histocompatibility-2-linked Ss-Slp region in the control of mouse complement.
    Proc Natl Acad Sci U S A. 1973 Mar;70(3):863-4 PMID: 4514997
  22. Linkage of HL-A and GBG.
    Vox Sang. 1974;27(4):382-4 PMID: 4414487
  23. Evidence for linkage between HL-A histocompatibility genes and those involved in the synthesis of the second component of complement.
    J Exp Med. 1974 Oct 1;140(4):1108-11 PMID: 4427089
  24. Immunochemical quantitation of antigens by single radial immunodiffusion.
    Immunochemistry. 1965 Sep;2(3):235-54 PMID: 4956917
  25. The serum bactericidal reaction. 3. Antibody and complement requirements for killing a rough Escherichia coli.
    J Immunol. 1969 Jun;102(6):1379-87 PMID: 4891549
  26. Human deficiency of the eighth component of complement. The requirement of C8 for serum Neisseria gonorrhoeae bactericidal activity.
    J Clin Invest. 1976 Feb;57(2):283-90 PMID: 815273
  27. Hereditary deficiency of the seventh component of complement.
    J Clin Invest. 1975 Oct;56(4):905-13 PMID: 1099121
  28. A new complement function: solubilization of antigen-antibody aggregates.
    Proc Natl Acad Sci U S A. 1975 Feb;72(2):418-22 PMID: 1054824
  29. Hereditary deficiency of the fifth component of complement in man. I. Clinical, immunochemical, and family studies.
    J Clin Invest. 1976 Jun;57(6):1626-34 PMID: 932197
  30. The membrane attack mechanism of complement: the three polypeptide chain structure of the eigth component (C8).
    J Exp Med. 1976 May 1;143(5):1131-9 PMID: 1262784
  31. Studies on the mechanism of solubilization of immune precipitates by serum.
    J Exp Med. 1976 Mar 1;143(3):615-30 PMID: 1249522
  32. Genetic linkage between serum levels of the third component of complement and the H-2 complex.
    J Exp Med. 1975 Feb 1;141(2):513-7 PMID: 1113067
  33. Inherited complement deficiencies and systemic lupus erythematosus: an immunogenetic puzzle.
    Ann Intern Med. 1975 Mar;82(3):420-1 PMID: 1115480
  34. Hereditary C2 deficiency: Genetic studies and association with the HL-A system.
    J Exp Med. 1975 Jun 1;141(6):1464-9 PMID: 1127385
  35. Biological activity of complement in vivo. Role of C5 in the accumulation of polymorphonuclear leukocytes in inflammatory exudates.
    J Exp Med. 1971 Nov 1;134(5):1131-43 PMID: 5112201
  36. Serotyping for homotransplantation. 18. Refinement of microdroplet lymphocyte cytotoxicity test.
    Transplantation. 1968 Nov;6(8):913-27 PMID: 5696820
  37. Complement dependent immune phagocytosis. I. Requirements for C'1, C'4, C'2, C'3.
    Exp Cell Res. 1968 Jul;51(1):45-67 PMID: 5661952
  38. Methods for the separation, purification and measurement of nine components of hemolytic complement in guinea-pig serum.
    Immunochemistry. 1966 Mar;3(2):111-35 PMID: 5960883
  39. Serum heat-labile opsonins in systemic lupus erythematosus.
    J Clin Invest. 1974 Feb;53(2):343-53 PMID: 11344546
Article Info
Journal
The Journal of clinical investigation
Abbr.
J Clin Invest
ISSN
0021-9738
Published
1977-09-00
Pages
709-15
Language
English
Region
United States
NLM ID
7802877
PMCID
PMC372416
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]